Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AGP Limited is a leading pharmaceutical company based in Pakistan, specializing in the manufacturing, marketing, and distribution of a wide range of healthcare products. Originally established as a subsidiary of Eli Lilly, the company has evolved into a prominent independent player while maintaining strategic licensing alliances with global pharmaceutical giants such as Lilly and Sandoz. Its extensive portfolio covers diverse therapeutic areas including anti-infectives, cardiology, gastroenterology, and orthopedics, featuring well-known brands like Ceclor and Osnate. AGP is publicly listed on the Pakistan Stock Exchange and has significantly expanded its market footprint through strategic acquisitions of international product portfolios. The company operates state-of-the-art manufacturing facilities that adhere to international quality standards, serving both domestic and export markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AGP Pharma.